{"id":67016,"date":"2025-09-30T10:32:11","date_gmt":"2025-09-30T10:32:11","guid":{"rendered":"https:\/\/biomedpharmajournal.org\/?p=67016"},"modified":"2025-10-14T04:30:07","modified_gmt":"2025-10-14T04:30:07","slug":"chemopreventive-effect-of-gliricidia-sepium-plant-extracts-in-mnu-induced-mammary-tumor-model","status":"publish","type":"post","link":"https:\/\/biomedpharmajournal.org\/staging\/vol18no3\/chemopreventive-effect-of-gliricidia-sepium-plant-extracts-in-mnu-induced-mammary-tumor-model\/","title":{"rendered":"Chemopreventive Effect of Gliricidia sepium Plant Extracts in MNU Induced Mammary Tumor Model"},"content":{"rendered":"<p>Introduction<\/p>\n<p>Breast cancer is the result of uncontrolled breast cell proliferation that develops into tumors. These tumors are typically palpable as lumps. The types of breast cancer and how they develop affect how they are treated. For the diagnosis, assessment, and treatment of breast cancer, a variety of innovative methods and surgical procedures are now accessible, which has improved the disease&#8217;s prognosis.<sup>1, <\/sup>In certain situations, a single breast tumor may combine elements of both invasive and in situ cancer types. Human breast cancer risk factors can be divided into two categories: risk factors that can be modified (things that can be changed, such as alcohol consumption) and fixed risk factors (things that have never shown symptoms of change, such as age and sex). Ionizing radiation, hormone replacement therapy for menopause, early age from the first month to the next, older age range, and hereditary factor.<sup>2<\/sup> Due to the mammary tissues of rodents and humans having a significant level of similarity, it is typically able to predict the course of mammary carcinogenesis in humans as well in experimental studies of breast cancer.<sup>3<\/sup> N-methyl N-nitrosourea (MNU) is a typical carcinogen that is utilized in rodents to cause breast cancer. Cribriform and papillary carcinomas were the most significantly caused lesions.<sup>4<\/sup> finding new sources of substances with therapeutic value depends on screening medicinal plants for phytochemicals. In addition to these expensive medicines, phytotherapy is currently one of accessible option to treat cancer. Major goal of our current research is to ascertain the extracts of <em>Gliricidia sepium <\/em>(GS) anticancer potential in order to develop a possible chemopreventive drug for human cancers, more research is required in order to identify and characterize its active principle and mechanism of action.<sup>5, 6<\/sup><\/p>\n<p><strong>\u00a0Materials and Methods<\/strong><\/p>\n<p><strong>Collection of plant and authentication<\/strong><\/p>\n<p><em>Gliricidia sepium <\/em>plant specimens were obtained from the districts of Sangli and Kolhapur, and they were further verified by the Botanical Survey of India (BSI) in Pune, with certificate reference number NO. BSI\/WRC\/100-1\/Tech.\/2020\/128 dated 28\/01\/2021.<\/p>\n<p><strong>Preparation of plant extract<\/strong><\/p>\n<p>\u00a0The collected aerial parts were washed and then dried under shade.\u00a0 The plant material was subjected to crushing, resulting in the production of coarsely powdered particles. The coarse particles were subsequently subjected to sequential extraction using chloroform, and ethanol solvents by using Soxhlet apparatus. <sup>7, 8<\/sup><\/p>\n<p><strong>Animal Experimentation<\/strong><\/p>\n<p>Female Wistar rats were used for all the experimental procedure and were obtained from animal house of Appasaheb Birnale college of pharmacy, sangli (Approved from CCSEA of Appasaheb Birnale college of pharmacy, sangli IAEC no: IAEC\/ABCP\/18\/2019-20) at 45<sup>th<\/sup> days of age weighing 150 \u2013 200 gm. The animals were kept in a 12-hour light\/dark cycle with typical laboratory settings. They were given food and water ad libitum. 42 animals were divided randomly into seven groups (N=6) N-methyl-N- nitrosourea (50 mg\/kg) dissolved in isotonic saline solution. The first dose of NMU injected by IP route on 45<sup>th<\/sup> \u00a0day postnatal day, second one on the 55<sup>th<\/sup> \u00a0day and 70<sup>th<\/sup> day postnatal day drug while standard drug tamoxifen, chloroform extract of <em>Gliricidia sepium <\/em>at dose of 200mg\/kg (CHGS 200) and ethanol extract of <em>Gliricidia sepium <\/em>at dose of 200mg\/kg (ETGS 200) were used as test compound and is administered from 1<sup>st<\/sup> \u00a0day of model after end of study model animal will be sacrificed for biochemical and Histopathological studies <sup>9,10,11<\/sup><\/p>\n<p><strong>Histopathology<\/strong><\/p>\n<p>Thin tissue slices (3\u20135 mm) were extracted from both normal and pathologically altered tissues. The samples were fixed in 10% formalin at room temperature for 24 to 48 hours. After fixation, the tissues were deparaffinized using xylene for 5 to 10 minutes, followed by dehydration with 100% alcohol. The sections were then stained with hematoxylin for 3 to 4 minutes and counterstained with 0.5% eosin for 15 to 30 seconds to achieve a pale pink appearance. After blotting, the slides were cleaned with xylene for 15 to 30 seconds, mounted with DPX, and dried to remove any air bubbles.<sup>12<\/sup><\/p>\n<p><strong>Determination of Antioxidant parameters<\/strong><\/p>\n<p>Antioxidants play a crucial role in cancer research and can be assessed through various parameters to understand their impact on cancer development, progression, and treatment. Antioxidants are compounds that protect cells from oxidative stress by neutralizing harmful free radicals, which can damage DNA and lead to cancer.<strong><sup>13<\/sup><\/strong> Here are some key antioxidant parameters commonly studied in the context of cancer:<\/p>\n<p><strong>Superoxide Dismutase (SOD)<\/strong><\/p>\n<p>One important enzyme in the body&#8217;s defense against oxidative stress is superoxide dismutase (SOD). It assists in transforming superoxide radicals into less dangerous compounds. With a final concentration of 0.1 M phosphate buffer (pH 6.5), 1 nM CDNB (1-chloro-2,4-dinitrobenzene) in 95% ethanol, and 1 mM GSH, the reaction volume (3 ml) was incubated for 5 minutes at 37 \u00b0C. The reaction was initiated by the addition of the enzyme sample, and for five minutes, the enzyme activity was monitored at 340 nm. <sup>14<\/sup><\/p>\n<p><strong>Catalase (CAT)<\/strong><\/p>\n<p>This antioxidant enzyme aids in the reduction of oxidative damage by dissolving hydrogen peroxide into oxygen and water. To start the reaction, 0.5 mL of hydrogen peroxide (H\u2082O\u2082) solution was added to 200 \u03bcL of diluted homogenate, 1.0 mL of phosphate buffer, and 0.4 mL of distilled water. In control test tubes, the hydrogen peroxide (H\u2082O\u2082) solution was not present. To halt the process, 2 mL of potassium dichromate acetic acid was added after it had been incubated for 1 minute at 37\u00b0C. After 15 minutes in a boiling water bath, the samples were cooled, and the absorbance at 570 nm was measured in comparison to the control.<sup>15<\/sup><\/p>\n<p><strong>Glutathione (GSH)<\/strong><\/p>\n<p>Glutathione is an essential intracellular antioxidant that participates in detoxification processes and helps protect cells from oxidative damage.<\/p>\n<p><strong>Analytical statistics<\/strong><\/p>\n<p>All of the data were compared using a one-way ANOVA and Dunnett&#8217;s posttest. Each outcome was reported as a rise or fall relative to the values of the control results. For all statistical studies, Graph Pad Prism version 8 was utilized. A variance was deemed statistically significant if p &lt; 0.05.<\/p>\n<p><strong>Results<\/strong><\/p>\n<p><strong>Effect of plant extract on body weight<\/strong><\/p>\n<p>As shown in table no 1 N-methyl-N-nitrosourea (NMU) was administered by intraperitoneal route, the body weight of the animals in the NMU control group significantly decreased (91.51\u00b10.45) from their starting weights. Simultaneous treatment of Tamoxifen (3.3 mg\/kg) and plant extracts of <em>Gliricidia sepium<\/em> orally resulted in a considerable rise Standard group (122.3\u00b10.66), TEST 1 CHGS 200 mg\/kg (116.3\u00b11.64) and TEST 2 ETGS 200mg\/kg (119.5\u00b11.37) in body weight when compared to the initial weight of the animals.<\/p>\n<p><strong>Table\u00a0 1: Animal Body Wight among different treatment groups<\/strong><\/p>\n<table style=\"width: 95%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"4\">\n<tbody>\n<tr style=\"height: 125px;\">\n<td style=\"text-align: center; height: 197px;\" rowspan=\"2\" width=\"179\">\n<p>Treatment Groups<\/p>\n<\/td>\n<td style=\"text-align: center; height: 125px;\" colspan=\"5\" width=\"498\">\n<p>Weekly measurement of body weight (gm)<\/p>\n<p>Mean \u00b1 SEM<\/p>\n<\/td>\n<td style=\"text-align: center; height: 197px;\" rowspan=\"2\" width=\"115\">\n<p>% Change in body weight from initial day of treatment<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"text-align: center; height: 72px;\" width=\"101\">\n<p>Initial day<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"87\">\n<p>1st week<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"102\">\n<p>2nd week<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"108\">\n<p>3rd week<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"100\">\n<p>4th week<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"text-align: center; height: 72px;\" width=\"179\">\n<p>NORMAL<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"101\">\n<p>91.17\u00b10.83<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"87\">\n<p>95.5\u00b11.6<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"102\">\n<p>101.7\u00b11.43<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"108\">\n<p>106.3\u00b11.76<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"100\">\n<p>111.7\u00b11.1<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"115\">\n<p>22.51<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"text-align: center; height: 72px;\" width=\"179\">\n<p>CONTROL<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"101\">\n<p>104.7\u00b1 1.66<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"87\">\n<p>101\u00b1 1.4<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"102\">\n<p>98.27\u00b1 1.08<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"108\">\n<p>95.04 \u00b10.51<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"100\">\n<p>91.51\u00b10.45<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"115\">\n<p>-12.59<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"text-align: center; height: 72px;\" width=\"179\">\n<p>STANDARD<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"101\">\n<p>102.5\u00b11.78<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"87\">\n<p>106.7\u00b11.28<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"102\">\n<p>111\u00b10.8<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"108\">\n<p>115\u00b11.50<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"100\">\n<p>122.3\u00b10.66<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"115\">\n<p>19.31<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"text-align: center; height: 72px;\" width=\"179\">\n<p>TEST 1 CHGS 200 mg\/kg<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"101\">\n<p>102.5\u00b12.14<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"87\">\n<p>105.5\u00b11.8<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"102\">\n<p>110\u00b11.8<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"108\">\n<p>112.5\u00b11.7<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"100\">\n<p>116.3\u00b11.64<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"115\">\n<p>13.46<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"text-align: center; height: 72px;\" width=\"179\">\n<p>TEST 2 ETGS 200mg\/kg<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"101\">\n<p>103.8\u00b11.51<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"87\">\n<p>110\u00b11.22<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"102\">\n<p>113.7\u00b11.53<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"108\">\n<p>117.5\u00b11.23<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"100\">\n<p>119.5\u00b11.37<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"115\">\n<p>15.12<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>\u00a0<\/p>\n<table style=\"width: 70%; border-collapse: collapse;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td style=\"width: 21.0049%;\"><img decoding=\"async\" class=\"alignnone size-full wp-image-67026\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig1.jpg\" alt=\"\" width=\"718\" height=\"496\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig1-300x207.jpg 300w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig1.jpg 718w\" sizes=\"(max-width: 718px) 100vw, 718px\" \/><\/td>\n<td style=\"width: 78.9951%;\">\n<p><strong>Figure 1: Graph of animal body weight<\/strong><\/p>\n<p>\u00a0<\/p>\n<p><a href=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig1.jpg\" target=\"_blank\" rel=\"noopener\">Click here to view Figure<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Effect of plant extract on Hematological parameter<\/strong><\/p>\n<p>It was observed that NMU induced control group and Tamoxifen treated standard group shows significantly decrease in haematological parameters. Simultaneous treatment of and plant extracts of <em>Gliricidia sepium <\/em>orally resulted in restoration and maintain normal\u00a0 Haematological Parameter as shown in table no 2<\/p>\n<p><strong>Table\u00a0 2: Hematological parameter<\/strong><\/p>\n<table style=\"width: 95%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"4\">\n<tbody>\n<tr style=\"height: 72px;\">\n<td style=\"text-align: center; height: 72px; width: 28.7197%;\" width=\"230\">\n<p>Treatment Groups<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px; width: 21.684%;\" width=\"173\">\n<p>Hb<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px; width: 23.7601%;\" width=\"189\">\n<p>RBC (millions\/cumm)<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px; width: 24.6828%;\" width=\"197\">\n<p>WBC (thousands\/cumm)<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"text-align: center; height: 72px; width: 28.7197%;\" width=\"230\">\n<p>\u00a0NORMAL<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px; width: 21.684%;\" width=\"173\">\n<p>14.75\u00b10.36<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px; width: 23.7601%;\" width=\"189\">\n<p>6.783\u00b10.36<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px; width: 24.6828%;\" width=\"197\">\n<p>8063\u00b1247.2<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 76px;\">\n<td style=\"text-align: center; height: 76px; width: 28.7197%;\" width=\"230\">\n<p>CONTROL<\/p>\n<\/td>\n<td style=\"text-align: center; height: 76px; width: 21.684%;\" width=\"173\">\n<p>11.52\u00b10.47<\/p>\n<\/td>\n<td style=\"text-align: center; height: 76px; width: 23.7601%;\" width=\"189\">\n<p>3.733\u00b10.25<\/p>\n<\/td>\n<td style=\"text-align: center; height: 76px; width: 24.6828%;\" width=\"197\">\n<p>6109\u00b1206.75<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"height: 72px; text-align: center; width: 28.7197%;\" width=\"230\">\n<p>STANDARD<\/p>\n<\/td>\n<td style=\"height: 72px; text-align: center; width: 21.684%;\" width=\"173\">\n<p>9.9\u00b10.12<\/p>\n<\/td>\n<td style=\"height: 72px; text-align: center; width: 23.7601%;\" width=\"189\">\n<p>3.417\u00b10.20<\/p>\n<\/td>\n<td style=\"height: 72px; text-align: center; width: 24.6828%;\" width=\"197\">\n<p>5007\u00b1210.6<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"height: 72px; text-align: center; width: 28.7197%;\" width=\"230\">\n<p>TEST 1 CHGS 200 mg\/kg<\/p>\n<\/td>\n<td style=\"height: 72px; text-align: center; width: 21.684%;\" width=\"173\">\n<p>11.83\u00b10.4364<\/p>\n<\/td>\n<td style=\"height: 72px; text-align: center; width: 23.7601%;\" width=\"189\">\n<p>4.383\u00b10.2286<\/p>\n<\/td>\n<td style=\"height: 72px; text-align: center; width: 24.6828%;\" width=\"197\">\n<p>7014\u00b1119.5<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"height: 72px; text-align: center; width: 28.7197%;\" width=\"230\">\n<p>TEST 2 ETGS 200mg\/kg<\/p>\n<\/td>\n<td style=\"height: 72px; text-align: center; width: 21.684%;\" width=\"173\">\n<p>12.18\u00b10.22<\/p>\n<\/td>\n<td style=\"height: 72px; text-align: center; width: 23.7601%;\" width=\"189\">\n<p>5.567\u00b10.28<\/p>\n<\/td>\n<td style=\"height: 72px; text-align: center; width: 24.6828%;\" width=\"197\">\n<p>7739\u00b1109.6<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong style=\"font-size: revert;\">\u00a0<\/strong><\/p>\n<table style=\"width: 70%; border-collapse: collapse;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td style=\"width: 22.8171%;\"><img decoding=\"async\" class=\"alignnone size-full wp-image-67027\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig2.jpg\" alt=\"\" width=\"847\" height=\"774\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig2-300x274.jpg 300w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig2-768x702.jpg 768w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig2.jpg 847w\" sizes=\"(max-width: 847px) 100vw, 847px\" \/><\/td>\n<td style=\"width: 77.1829%;\">\n<p><strong style=\"font-size: revert;\">Figure 2: Graph of Hematological Parameter A) Hemoglobin Content B) RBC count C) WBC Count<\/strong><\/p>\n<p>\u00a0<\/p>\n<p><a href=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig2.jpg\" target=\"_blank\" rel=\"noopener\">Click here to view Figure<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Tumourological Parameters<\/strong><\/p>\n<p>The effect of <em>Gliricidia sepium <\/em>plant extract on tumor parameters observation in figure no.: 5 and result obtained. It was seen that tumor parameters such as tumor incidence, \u00a0 tumor volume, tumor weight, and tumor burden in the MNU induced control group are increased as compared to normal animals. The tumor indicators listed above significantly decreased. Among treatment groups of the tamoxifen\u00a0and the <em>Gliricidia sepium <\/em>extract treated group. In test groups, chloroform and ethanol extracts were used, but among them it was found that Ethanol extract showed more significant results in comparison with chloroform extract treated group. \u00a0<\/p>\n<p><strong>Table 3: Tumor Parameter<\/strong><\/p>\n<table style=\"width: 95%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"4\">\n<tbody>\n<tr>\n<td style=\"text-align: center;\" width=\"227\">\n<p><strong>Treatment Groups<\/strong><\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"173\">\n<p><strong>Tumor mass (g)<\/strong><\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"188\">\n<p><strong>Tumor size (mm)<\/strong><\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"203\">\n<p><strong>Tumor Incidence<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center;\" width=\"227\">\n<p>NORMAL<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"173\">\n<p>0<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"188\">\n<p>0<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"203\">\n<p>0<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center;\" width=\"227\">\n<p>CONTROL<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"173\">\n<p>23.35\u00b14.8<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"188\">\n<p>30.41\u00b12.9<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"203\">\n<p>87.63<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center;\" width=\"227\">\n<p>STANDARD<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"173\">\n<p>10\u00b12.56<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"188\">\n<p>15\u00b16.16<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"203\">\n<p>34<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center;\" width=\"227\">\n<p>TEST 1 CHGS 200 mg\/kg<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"173\">\n<p>13\u00b13.78<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"188\">\n<p>18\u00b12.35<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"203\">\n<p>46<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center;\" width=\"227\">\n<p>TEST 2 ETGS 200mg\/kg<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"173\">\n<p>11\u00b14.34<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"188\">\n<p>16.34\u00b13.12<\/p>\n<\/td>\n<td style=\"text-align: center;\" width=\"203\">\n<p>41<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Histopathology \u00a0<\/strong><\/p>\n<p>As shown in figure no.: 4 a breast section from normal rats (N1) showed no evidence of malignancy (D-Duct). MNU induced rats (C1) showed hyperplasia of the acinar epithelium and atypical ductal hyperplasia. The MNU-induced tamoxifen-treated group (S1 and S2) and the plant extract-treated group show reduced proliferative activity in the mammary gland. Specifically, it inhibited the incidence of ductal carcinoma in situ (DCIS) or intraductal papilloma (IDP).<\/p>\n<p><strong>In vivo antioxidant activity<\/strong><\/p>\n<p>Oxidative stress is associated with cancer, antioxidant parameters were conducted on\u00a0 mammary carcinoma in female rats. The liver tissues of every test rat had the following antioxidant enzymes measured. As results shown in table no. 4.<\/p>\n<p><strong>Effect of Plant extract on superoxide dismutase (SOD)<\/strong><\/p>\n<p>Animals administered MNU showed a significant reduction in SOD levels (2.82\u00b10.01) in control group and it decreases below to normal level (6.40\u00b10.047). When rats given MNU were given treatment with extracts of <em>Gliricidia sepium <\/em>SOD concentrations increased significantly in ethanol extract (4.96\u00b10.005) as comparison with chloroform (3.9\u00b10.019) SOD level as displayed in Table no 4. According to the findings from the treated ethanolic extract aggregate, a significant increase as comparison with normal \u00a0SOD was seen in the case of MNU rats administered tamoxifen.<\/p>\n<p><strong>Effect of Plant extract on catalase (CAT)<\/strong><\/p>\n<p>Compared to normal rats, MNU-induced animals had lower levels of catalase\u201426.34 \u00b1 0.01 unit\/mg. It appears that the reduction is statistically significant. CAT levels increased in MNU-induced rats when G. sepium extract was administered. The CAT level was 17.42 \u00b1 0.01 unit\/mg when the chloroform extract was administered, and it changed when the ethanol extract was given, as shown in table no 4. Tamoxifen-treated MNU rats showed a significant increase in CAT, which is consistent with the findings from the group that received ethanol extract treatment.<sup>16<\/sup><\/p>\n<p><strong>Effect of Plant extract on Reduced glutathione (GSH) nmol\/mg<\/strong><\/p>\n<p>Compared to normal rats (7.3\u00b10.043) , MNU-induced animals showed a significant drop in GSH levels (1.8 \u00b1 0.13). GSH levels increased in MNU-induced rats when <em>Gliricidia sepium <\/em>extract was administered. The amount of GSH in the tissue was 3.4 \u00b1 0.34 mg\/g when chloroform extract was administered, and this changed to 3.9 \u00b1 0.14 mg\/g when ethanol extract was given. Data from the ethanol extract-treated group coincides with the considerable increase in GSH shown in the case of MNU rats treated with tamoxifen.<\/p>\n<p><strong>Table 4: Antioxidant Parameter<\/strong><\/p>\n<table style=\"width: 95%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"4\">\n<tbody>\n<tr style=\"height: 106px;\">\n<td style=\"text-align: center; height: 106px;\" width=\"210\">\n<p><strong>Treatment Groups<\/strong><\/p>\n<\/td>\n<td style=\"text-align: center; height: 106px;\" width=\"195\">\n<p><strong>Superoxide dismutase (SOD) U\/mg of protein<\/strong><\/p>\n<\/td>\n<td style=\"text-align: center; height: 106px;\" width=\"180\">\n<p><strong>Reduced glutathione (GSH) nmol\/mg<\/strong><\/p>\n<\/td>\n<td style=\"text-align: center; height: 106px;\" width=\"203\">\n<p><strong>Catalase (CAT) U\/mg of protein<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"text-align: center; height: 72px;\" width=\"210\">\n<p>NORMAL<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"195\">\n<p>6.40\u00b10.047<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"180\">\n<p>7.3\u00b10.043<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"203\">\n<p>26.34\u00b10.012<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"text-align: center; height: 72px;\" width=\"210\">\n<p>CONTROL<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"195\">\n<p>2.82\u00b10.01<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"180\">\n<p>1.8\u00b10.134<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"203\">\n<p>8.52\u00b10.04<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"text-align: center; height: 72px;\" width=\"210\">\n<p>STANDARD<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"195\">\n<p>6.068\u00b10.028<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"180\">\n<p>5.6\u00b10.030<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"203\">\n<p>23.14\u00b10.045<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"text-align: center; height: 72px;\" width=\"210\">\n<p>TEST 1 CHGS 200 mg\/kg<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"195\">\n<p>3.9\u00b10.019<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"180\">\n<p>3.4\u00b10.34<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"203\">\n<p>17.42\u00b10.01<\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 72px;\">\n<td style=\"text-align: center; height: 72px;\" width=\"210\">\n<p>TEST 2 ETGS 200mg\/kg<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"195\">\n<p>4.96\u00b10.005<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"180\">\n<p>3.9\u00b10.14<\/p>\n<\/td>\n<td style=\"text-align: center; height: 72px;\" width=\"203\">\n<p>21.34\u00b10.023<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong style=\"font-size: revert;\">\u00a0<\/strong><\/p>\n<table style=\"width: 70%; border-collapse: collapse;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td style=\"width: 22.8171%;\"><img decoding=\"async\" class=\"alignnone size-full wp-image-67028\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig3.jpg\" alt=\"\" width=\"779\" height=\"585\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig3-300x225.jpg 300w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig3-768x577.jpg 768w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig3.jpg 779w\" sizes=\"(max-width: 779px) 100vw, 779px\" \/><\/td>\n<td style=\"width: 77.1829%;\">\n<p><strong>Figure 3: Graph of Anti-oxidant parameter A: SOD, B: GSH, C: CAT.<\/strong>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p><a href=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig3.jpg\" target=\"_blank\" rel=\"noopener\">Click here to view Figure<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>\u00a0<\/p>\n<p><strong style=\"font-size: revert;\">\u00a0<\/strong><\/p>\n<table style=\"width: 70%; border-collapse: collapse;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td style=\"width: 22.8171%;\"><img decoding=\"async\" class=\"alignnone size-full wp-image-67029\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig4.jpg\" alt=\"\" width=\"805\" height=\"577\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig4-300x215.jpg 300w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig4-768x550.jpg 768w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig4.jpg 805w\" sizes=\"(max-width: 805px) 100vw, 805px\" \/><\/td>\n<td style=\"width: 77.1829%;\">\n<p><strong>Figure 4: H&amp;E-stained paraffin sections N1- Normal, C1- Control shows A- Hyperplasia of acinar epithelium and B shows Atypical ductal hyperplasia, S1, S2- Standard, Test 1 CHGS- Chloroform extract of <em>Gliricidia sepium <\/em>and Test 2 ETGS Ethanol extract of <em>Gliricidia sepium<\/em><\/strong><\/p>\n<p>\u00a0<\/p>\n<p><a href=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig4.jpg\" target=\"_blank\" rel=\"noopener\">Click here to view Figure<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>\u00a0<\/p>\n<p><strong style=\"font-size: revert;\">\u00a0<\/strong><\/p>\n<table style=\"width: 70%; border-collapse: collapse;\" border=\"1\" cellpadding=\"5\">\n<tbody>\n<tr>\n<td style=\"width: 22.8171%;\"><img decoding=\"async\" class=\"alignnone size-full wp-image-67030\" src=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig5.jpg\" alt=\"\" width=\"654\" height=\"519\" srcset=\"https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig5-300x238.jpg 300w, https:\/\/biomedpharmajournal.org\/staging\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig5.jpg 654w\" sizes=\"(max-width: 654px) 100vw, 654px\" \/><\/td>\n<td style=\"width: 77.1829%;\">\n<p><strong>Figure 5: <span style=\"font-size: revert;\">Mammary tumors isolated from various treatment groups <\/span>A- Control Group animal with. Mammary tumor B- Control Group C- Standard D- TEST 1 CHGS 200 mg\/kg E- TEST 2 ETGS 200mg\/kg<\/strong><\/p>\n<p>\u00a0<\/p>\n<p><a href=\"https:\/\/biomedpharmajournal.org\/wp-content\/uploads\/2025\/07\/Vol18No3_Chet_Sud_Fig5.jpg\" target=\"_blank\" rel=\"noopener\">Click here to view Figure<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Discussion<\/strong><\/p>\n<p>Carcinogenesis is an intricate and unpredictable process, often involving unexpected molecular and cellular pathways. Despite the extensive body of knowledge regarding its causes, mechanisms, and progression, cancer remains a formidable and vulnerable disease. Mortality and morbidity rates continue to be alarmingly high, even with advances in diagnostic tools and therapeutic strategies.<sup> 17, 18<\/sup><\/p>\n<p>In recent years, plant-derived natural compounds have attracted considerable interest in medical research due to their diverse pharmacological properties, particularly their antioxidant and anticancer activities. Numerous studies using various cancer cell lines have demonstrated the therapeutic potential of plant extracts in combating malignancies. Furthermore, there has been a significant increase in the use of complementary therapies such as dietary supplements and phototherapeutic products especially among women with a history of breast cancer.<sup> 19,20<\/sup><\/p>\n<p>Most in vitro research has centered on mechanisms such as free radical scavenging, apoptosis-induced cytotoxicity, and DNA damage. However, in vivo models are critical, as they provide histopathological evidence to distinguish between benign and malignant tumors. Traditional cancer treatments often fall short of delivering optimal results, prompting the exploration of alternative therapies.<sup> 21,22<\/sup><\/p>\n<p>One such alternative is <em>Gliricidia sepium<\/em>, whose antitumor effects have been evaluated in rodent models bearing induced tumors. In the present study, body weight was monitored throughout the experimental period. The weight loss observed in the MNU-treated (control) group was likely due to increased metabolic demand and systemic cancer-related effects. In contrast, the treatment group exhibited a comparatively higher percentage gain in body weight, indicating a potential protective role of the plant extract in countering cancer-induced weight loss.<sup> 23,24<\/sup><\/p>\n<p>Histological analysis provided further evidence of tumor regression in the treated group, revealing a significant reduction in proliferative activity within the mammary gland tissue. Notably, the treatment inhibited the development of ductal carcinoma in situ (DCIS) and intraductal papilloma (IDP), both of which are precancerous lesions.<sup>25, 26<\/sup><\/p>\n<p>Reduced glutathione (GSH) is vital for maintaining cellular viability, acting as a major intracellular antioxidant that protects cells against oxidative damage by neutralizing reactive oxygen species (ROS). Previous studies have shown that GSH depletion in mammary cancer models is associated with increased lipid peroxidation, a process that damages cellular membranes and contributes to carcinogenesis. Moreover, tumor cells often exhibit heightened GSH consumption due to their rapid proliferation and increased metabolic demand, indicating its complex role in tumor biology. In this study, treatment with Gliricidia sepium led to significantly lower malondialdehyde (MDA) levelsa biomarker of lipid peroxidationand elevated serum GSH levels, suggesting a reduction in oxidative stress and an enhancement of the endogenous antioxidant defense system. This biochemical shift indicates that G. sepium may mitigate the oxidative environment typically favorable for cancer progression. The role of antioxidants in cancer therapy is multifaceted. On one hand, they can scavenge harmful free radicals and inhibit oxidative DNA damage, thus preventing the initiation and promotion stages of carcinogenesis. On the other hand, enhancing antioxidant capacity in normal tissues may help reduce the side effects of conventional therapies such as chemotherapy and radiotherapy, which often generate excessive ROS. In the context of G. sepium treatment, the observed increase in GSH and decrease in MDA suggest a protective effect on cellular components and a potential inhibitory effect on tumor growth and proliferation.<\/p>\n<p>By restoring redox balance, antioxidants may help induce apoptosis in malignant cells, modulate signaling pathways involved in cell cycle regulation, and suppress angiogenesis and metastasis. Therefore, the antioxidant properties of Gliricidia sepium could play a pivotal role in curbing breast tumor development, supporting its potential as a complementary therapeutic agent in breast cancer management.<sup>27, 28<\/sup><\/p>\n<p><strong>Conclusion<\/strong><\/p>\n<p>Conventional cancer therapies often have limitations, leading to growing interest in plant-derived compounds for their anticancer potential. Both plant extracts of <em>Gliricidia sepium <\/em>has demonstrated promising antitumor activity but ethanol extract shows more promising result than chloroform by reducing tumor proliferation and enhancing antioxidant defense mechanisms in mammary cancer models. Its ability to lower lipid peroxidation and increase glutathione levels suggests a protective effect against oxidative stress in breast tissue. The findings indicate that plant-based therapies could serve as complementary treatments for cancer management. However, further clinical studies are necessary to validate these effects and explore their therapeutic applications in humans.<\/p>\n<p><strong>Acknowledgement<\/strong><\/p>\n<p>Authors are thankful to the principal and management Appasaheb Birnale College of Pharmacy, Sangli for provided lab facility and chemicals for the present investigation.\u00a0<\/p>\n<p><strong>Funding Sources<\/strong><\/p>\n<p>The author(s) received no financial support for the research, authorship, and\/or publication of this article.<\/p>\n<p><strong>Conflict of Interest<\/strong><\/p>\n<p>The author(s) do not have any conflict of interest.<\/p>\n<p><strong>Data Availability Statement<\/strong><\/p>\n<p>This statement does not apply to this article.<\/p>\n<p><strong>Ethics Statement<\/strong><\/p>\n<p>This research involves an experiment on animals that requires ethical approval, Ethical approval has been taken from CCSEA of appasaheb birnale college of pharmacy, sangli IAEC no: IAEC\/ABCP\/18\/2019-20.<\/p>\n<p><strong>Informed Consent Statement<\/strong><\/p>\n<p>This study did not involve human participants, and therefore, informed consent was not required.<\/p>\n<p><strong>Clinical Trial Registration<\/strong><\/p>\n<p>This research does not involve any clinical trials<\/p>\n<p><strong>Permission to reproduce material from other sources<\/strong><\/p>\n<p>Not Applicable<strong>\u00a0<\/strong><\/p>\n<p><strong>Author Contributions<\/strong><\/p>\n<ul>\n<li><strong>Sudhir Patil:<\/strong> Conceptualization, Methodology, Writing \u2013 review and editing, Visualization, Investigation, Formal analysis.<\/li>\n<li><strong>Kiran Wadkar:<\/strong> Methodology, Software, Validation, Formal analysis, Resources, Supervision, Project administration<\/li>\n<\/ul>\n<p><strong>References<\/strong><\/p>\n<ol>\n<li>Waks A. G., Winer E. P. Breast cancer treatment: a review. <em>Jama<\/em>. 2019;321(3):288-300.<br \/><a href=\"https:\/\/doi.org\/10.1001\/jama.2018.19323\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Weigelt B., Geyer F. C., Reis-Filho J. S. Histological types of breast cancer: how special are they?. <em>Molecular oncology<\/em>. 2010; 4(3):192-208.<br \/><a href=\"https:\/\/doi.org\/10.1016\/j.molonc.2010.04.004\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Bazm MA, Naseri L, Khazaei M. Methods of inducing breast cancer in animal models: A systematic review. <em>World Cancer Res J<\/em>. 2018; 5(4):e1182.<\/li>\n<li>Samuels N., Ben-Arye E., Maimon Y., Berger R. Unmonitored use of herbal medicine by patients with breast cancer: reframing expectations. <em>Journal of cancer research and clinical oncology. <\/em>2017;143: 2267-2273.<br \/><a href=\"https:\/\/doi.org\/10.1007\/s00432-017-2471-x\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Abdulaziz A. A., Dapar M.L., Manting M. M., Torres A. J., Aranas A. T., Mindo R. A., Cabrido C. K., Demayo C. G. Qualitative evaluation of the antimicrobial, antioxidant, and medicinally important phytochemical constituents of the ethanolic extracts of the leaves of <em>Gliricidia sepium <\/em>(Jacq.). <em> 2019<\/em>;10(4):72-83.<\/li>\n<li>Odey M. O., Iwara I. A., Udiba U. U., Johnson J. T., Inekwe U. V., Asenye M. E., Victor O. Preparation of plant extracts from indigenous medicinal plants. <em>International Journal of Science and Technolo<\/em> 2012;1(12):688-692.<\/li>\n<li>Huie C. W. A review of modern sample-preparation techniques for the extraction and analysis of medicinal plants. <em>Analytical and bioanalytical chemistry<\/em>. 2002;373:23-30.<br \/><a href=\"https:\/\/doi.org\/10.1007\/s00216-002-1265-3\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Garrone O., Ruatta F., Rea C. G., Denaro N., Ghidini M., Cauchi C., Bareggi C., Galassi B., Merlano M. C., Rosenfeld R. Current Evidence in the Systemic Treatment of Brain Metastases from Breast Cancer and Future Perspectives on New Drugs, Combinations and Administration Routes: A Narrative Review. 2024;16(24):4164.<br \/><a href=\"https:\/\/doi.org\/10.3390\/cancers16244164\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Kim D. J., Takasuka N., Kim J. M., Sekine K., Ota T., Asamoto M., Murakoshi M., Nishino H., Nir Z., Tsuda H. Chemoprevention by lycopene of mouse lung neoplasia after combined initiation treatment with DEN, MNU and DMH. <em>Cancer letters.<\/em> 1997;120(1):15-22.<br \/><a href=\"https:\/\/doi.org\/10.1016\/S0304-3835(97)00281-4\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Ahmed AS, Elbahnasawy MA, Mahgoub HA, Maarouf RE. Impact of Clostridium sporogenes endospores and boswellic acid on breast cancer induced by N-Nitroso-N-methyl urea (MNU) in female rats. <em>Microbial Biosystems<\/em>. 2025:1;10(1).<br \/><a href=\"https:\/\/doi.org\/10.21608\/mb.2024.322764.1184\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Sharmila G., Athirai T., Kiruthiga B., Senthilkumar K., Elumalai P., Arunkumar R., Arunakaran J. Chemopreventive effect of quercetin in MNU and testosterone induced prostate cancer of Sprague-Dawley rats. <em>Nutrition and cancer.<\/em> 2014;66(1):38-46.<br \/><a href=\"https:\/\/doi.org\/10.1080\/01635581.2014.847967\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Slaoui M., Fiette L. Histopathology procedures: from tissue sampling to histopathological evaluation. Drug Safety Evaluation: <em>Methods and Protocols<\/em>. 2011;69-82.<br \/><a href=\"https:\/\/doi.org\/10.1007\/978-1-60761-849-2_4\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Singh K, Bhori M, Kasu YA, Bhat G, Marar T. Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity\u2013Exploring the armoury of obscurity. <em>Saudi Pharmaceutical Journal<\/em>. 2018;26(2):177-90.<br \/><a href=\"https:\/\/doi.org\/10.1016\/j.jsps.2017.12.013\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Jayakumar T, Sakthivel M, Thomas PA, Geraldine P. Pleurotus ostreatus, an oyster mushroom, decreases the oxidative stress induced by carbon tetrachloride in rat kidneys, heart and brain. <em>Chemico-Biological Interactions<\/em>. 2008;176 (2-3):108-20.<br \/><a href=\"https:\/\/doi.org\/10.1016\/j.cbi.2008.08.006\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Al-Numair KS, Chandramohan G, Veeramani C, Alsaif MA. Ameliorative effect of kaempferol, a flavonoid, on oxidative stress in streptozotocin-induced diabetic rats. <em>Redox Report.<\/em> 2015; 20(5):198-209.<br \/><a href=\"https:\/\/doi.org\/10.1179\/1351000214Y.0000000117\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Younus H. Therapeutic potentials of superoxide dismutase. <em>International journal of health sciences<\/em>. 2018;12(3):88.<\/li>\n<li>Ladas E. J., Jacobson J. S., Kennedy D. D., Teel K., Fleischauer A., Kelly K. M. Antioxidants and cancer therapy: a systematic review. <em>Journal of clinical oncology.<\/em> 2004;22(3):517-528.<br \/><a href=\"https:\/\/doi.org\/10.1200\/JCO.2004.03.086\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Karia PD, Patil LA, Vakani MS, et al. Chemoprevention of breast cancer by Psidium guajava Linn. <em>Asian J Pharm Pharmacol<\/em>. 2018;5(1):58-68.<br \/><a href=\"https:\/\/doi.org\/10.31024\/ajpp.2019.5.1.8\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Atanasov A. G., Waltenberger B., Pferschy-Wenzig E. M., Linder T., Wawrosch C., Uhrin P., Temml V., Wang L., Schwaiger S., Heiss E. H., Rollinger J. M. Discovery and resupply of pharmacologically active plant-derived natural products: A review. <em>Biotechnology advances.<\/em> 2015;33(8):1582-1614.<br \/><a href=\"https:\/\/doi.org\/10.1016\/j.biotechadv.2015.08.001\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Bhat GR, Sethi I, Sadida HQ, Rah B, Mir R, Algehainy N, Albalawi IA, Masoodi T, Subbaraj GK, Jamal F, Singh M. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance. <em>Cancer and Metastasis Reviews.<\/em> 2024;43(1):197-228.<br \/><a href=\"https:\/\/doi.org\/10.1007\/s10555-024-10172-z\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Engel N., Oppermann C., Falodun A., Kragl U. Proliferative effects of five traditional Nigerian medicinal plant extracts on human breast and bone cancer cell lines. <em>Journal of ethnopharmacology.<\/em> 2011;137(2):1003-1010.<br \/><a href=\"https:\/\/doi.org\/10.1016\/j.jep.2011.07.023\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Ng C. X., Affendi M. M., Chong P. P., Lee S. H. The potential of plant-derived extracts and compounds to augment anticancer effects of chemotherapeutic drugs. <em>Nutrition and Cancer.<\/em> 2022;74(9):3058-76.<br \/><a href=\"https:\/\/doi.org\/10.1080\/01635581.2022.2069274\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Karakas SM, Yilmaz A, Mercantepe T, Topcu A, Pinarbas E. Positive effects of white tea on breast cancer: N-methyl-N-nitrozourea intraductal induced breast carcinoma model. Journal of Functional Foods. 2024;122:106462.<br \/><a href=\"https:\/\/doi.org\/10.1016\/j.jff.2024.106462\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Valko M., Rhodes C. J., Moncol J., Izakovic M. M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. <em>Chemico-biological interactions<\/em>. 2006;160(1):1-40.<br \/><a href=\"https:\/\/doi.org\/10.1016\/j.cbi.2005.12.009\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Vera-Ramirez L., Sanchez-Rovira P., Ramirez-Tortosa M. C., Ramirez-Tortosa C. L., Granados-Principal S., Lorente J. A., Quiles J. L. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. <em>Critical reviews in oncology\/hematology<\/em>. 2011;80(3):347-68.<br \/><a href=\"https:\/\/doi.org\/10.1016\/j.critrevonc.2011.01.004\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Mandard A. M., Dalibard F., Mandard J. C., Marnay J., Henry\u2010Amar M., Petiot J. F., Roussel A., Jacob J. H., Segol P., Samama G., Ollivier J. M. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. <em>Clinicopathologic correlations. Cancer.<\/em> 1994;73(11):2680-2686.<br \/><a href=\"https:\/\/doi.org\/10.1002\/1097-0142(19940601)73:11&lt;2680::AID-CNCR2820731105&gt;3.0.CO;2-C\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Jamshidifar E, Eshrati Yeganeh F, Shayan M, Tavakkoli Yaraki M, Bourbour M, Moammeri A, Akbarzadeh I, Noorbazargan H, Hossein-Khannazer N. Super magnetic niosomal nanocarrier as a new approach for treatment of breast cancer: a case study on SK-BR-3 and MDA-MB-231 cell lines. <em>International journal of molecular sciences<\/em>. 2021 26;22(15):7948.<br \/><a href=\"https:\/\/doi.org\/10.3390\/ijms22157948\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<li>Gal AF, Stan L, T\u0103b\u0103ran F, Rugin\u0103 D, C\u0103toi AF, Andrei S. Chemopreventive Effects of Propolis in the MNU\u2010Induced Rat Mammary Tumor Model. <em>Oxidative Medicine and Cellular Longevity<\/em>. 2020; 2020(1):4014838.<br \/><a href=\"https:\/\/doi.org\/10.1155\/2020\/4014838\" target=\"_blank\" rel=\"noopener\">CrossRef<\/a><\/li>\n<\/ol>\n\n","protected":false},"excerpt":{"rendered":"<p>Introduction Breast cancer is the result of uncontrolled breast cell  [&#8230;]<\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[128],"tags":[],"class_list":["post-67016","post","type-post","status-publish","format-standard","hentry","category-vol18no3"],"_links":{"self":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/67016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/comments?post=67016"}],"version-history":[{"count":5,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/67016\/revisions"}],"predecessor-version":[{"id":68305,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/67016\/revisions\/68305"}],"wp:attachment":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/media?parent=67016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/categories?post=67016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/tags?post=67016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}